Skip to main content
SpringerLink
Log in

Special Therapeutic Options and Substances in the Treatment of Atopic Eczema

  • Chapter
Atopic Dermatitis

  • 2338 Accesses

Abstract

The introduction of glucocorticosteroids in dermatology was the greatest progress for eczema patients in the second half of the twentieth century. For atopic dermatitis, mostly mild to moderate strength steroids are adequate. The application of topical glucocorticosteroids in the correct vehicle should be timely limited and ended via a “tandem therapy.” Proactive strategies with once or twice weekly applications of the effective substance have proven helpful. The most important side effects of topical glucocorticosteroids include skin atrophy and the common manifestation of perioral rosacea-like dermatitis which occurs especially in young women after topical corticosteroids.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Naldi L, Mercury SR. Chronic pruritus management: a plea for improvement – can itch clinics be an option? Dermatology. 2010;221:216–8.

    Article  PubMed  Google Scholar 

  • Kini SP, De Long LK, Veledar E, McKenzie-Brown AM, Schaufele M, Chen SC. The impact of pruritus on quality of life: the skin equivalent of pain. Arch Dermatol. 2011;147:312–9.

    Google Scholar 

  • Ständer S, Zeidler C, Magnolo N, Raap U, Mettang T, Kremer AE, Weisshaar E, Augustin M. Clinical management of pruritus. J Dtsch Dermatol Ges. 2015;13:101–15.

    PubMed  Google Scholar 

  • Hafenreffer S. Nosodochium, in quo cutis, eique adaerentium partium, affectus omnes, singulari methodo, et cognoscendi e curandi fidelisime traduntur. Ulm: Kuhnen; 1660. p. 98–102.

    Google Scholar 

  • Traidl-Hoffmann C, Münster I, Ring J, Behrendt H. Impact of desloratadine on the crosstalk between human keratinocytes and leukocytes: implications for anti-inflammatory activity of antihistamines. Int Arch Allergy Immunol. 2006;140:315–20.

    Article  CAS  PubMed  Google Scholar 

  • Bovet D, Staub AM. Action protectrice des éthers-phénoliques au cours de l’intoxication histaminique. C R Soc Biol Paris. 1934;124:547–9.

    Google Scholar 

  • Cowden JM, Zhang M, Dunford PJ, Thurmond RL. The histamine H4 receptor mediates inflammation and pruritus in Th2-dependent dermal inflammation. J Invest Dermatol. 2010;130:1023–33.

    Article  CAS  PubMed  Google Scholar 

  • Ashida Y, Denda M, Hirao T. Histamine H1 and H2 receptor antagonists accelerate skin barrier repair and prevent epidermal hyperplasia induced by barrier disruption in a dry environment. J Invest Dermatol. 2001;116:261–5.

    Article  CAS  PubMed  Google Scholar 

  • Church MK. Non-H1-receptor effects of antihistamines. Clin Exp Allergy. 1999;29 Suppl 3:39–48.

    CAS  PubMed  Google Scholar 

  • Hjorth N, Schmidt H, Thomsen K. Fusidic acid plus betamethasone in infected or potentially infected eczema. Pharmatherapeutica. 1985;4(2):126–31.

    CAS  PubMed  Google Scholar 

  • Luger T, Boguniewicz M, Carr W, Cork M, Deleuran M, Eichenfield L, Eigenmann P, Fölster-Holst R, Gelmetti C, Gollnick H, Hamelmann E, Hebert AA, Muraro A, Oranje AP, Paller AS, Paul C, Puig L, Ring J, Siegfried E, Spergel JM, Stingl G, Taieb A, Torrelo A, Werfel T, Wahn U. Pimecrolimus in atopic dermatitis: consensus on safety and the need to allow use in infants. Pediatr Allergy Immunol. 2015;26:306–15.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sigurgeirsson B, Boznanski A, Todd G, Vertruyen A, Schuttelaar ML, Zhu X, et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trial. Pediatrics. 2015;135:597–606.

    Article  PubMed  Google Scholar 

  • Alomar A, Berth-Jones J, Bos JD, et al. The role of topical calcineurin inhibitors in atopic dermatitis. Br J Dermatol. 2004;151 Suppl 70:3–27.

    Article  CAS  PubMed  Google Scholar 

  • Luger TA, Van Leent EJ, Graeber M, Hedgecock S, Thurston M, Kandra A, Berth Jones J, Bjerke J, Christophers E, Knop J, Knulst AC, Morren M, Morris A, Reitamo S, Roed-Petersen J, Schöpf E, Thestrup-Pedersen K, Van der Valk PGM, Bos J. SDZ ASM981: an emerging new standard for the treatment of atopic dermatitis. Br J Dermatol. 2001;144:788–94.

    Article  CAS  PubMed  Google Scholar 

  • Fisher MS, Kripke ML. Systemic alteration induced by UV light irradiation. PNAS. 1977;74:1688–92.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Grüber C. Probiotics and prebiotics in allergy prevention and treatment: future prospects. Expert Rev Clin Immunol. 2012;8(1):17–9. doi:10.1586/eci.11.74.

    Article  PubMed  CAS  Google Scholar 

  • Papp K, Cather JC, Rosoph L, Sofen H, Langley RG, Matheson RT, Hu C, Day RM. Efficacy of apremilast in the treatment of moderate to severe psoriasis: a randomised controlled trial. Lancet. 2012;380(9843):738–46.

    Article  CAS  PubMed  Google Scholar 

  • Akhavan A, Rudikoff D. The treatment of atopic dermatitis with immunosuppressive agents. Clin Dermatol. 2003;21:225–40.

    Article  PubMed  Google Scholar 

  • Buhl R, Hanf G, Soler M, Bensch G, et al. The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. Eur Resp J. 2002;20:1088–94.

    Google Scholar 

  • Stangier U. Hautkrankheiten und körperdysmorphe Störung. Fortschritte der Psychotherapie. Göttingen: Hogrefe; 2001.

    Google Scholar 

  • Rosenfeldt V, Benfeldt E, Nielsen SD, Michaelsen KF, Jeppesen DL, Valerius NH, Paerregaard A. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol. 2003;111(2):389–95.

    Article  PubMed  Google Scholar 

  • Krueger JG, Ferris LK, Menter A, Wagner F, White A, Visvanathan S, Lalovic B, Aslanyan S, Wang EE, Hall D, Solinger A, Padula S, Scholl P. Anti-IL-23A mAb BI 655066 for treatment of moderate-to-severe psoriasis: safety, efficacy, pharmacokinetics, and biomarker results of a single-rising-dose, randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2015;136(1):116–124.e7. doi:10.1016/j.jaci.2015.01.018. Epub 2015 Mar 11.

    Article  CAS  PubMed  Google Scholar 

  • Cassano N, Loconsole F, Coviello C, Vena GA. Infliximab in recalcitrant severe atopic eczema associated with contact allergy. Int J Immunopathol. 2006;19:237–40.

    Google Scholar 

  • Milgrom H, Berger W, Nayak A, Gupta N, Pollard S. Treatment of childhood asthma with anti-immunoglobulin E antibody (omalizumab). Pediatrics. 2001;108:36–45.

    Article  Google Scholar 

  • Fajt ML, Wenzel SE. Biologic therapy in asthma: entering the new age of personalized medicine. J Asthma. 2014;51(7):669–76.

    Article  CAS  PubMed  Google Scholar 

  • Papp KA, Griffiths CE, Gordon K, Lebwohl M, Szapary PO, Wasfi Y, Chan D, Hsu MC, Ho V, Ghislain PD, Strober B, Reich K, PHOENIX 1 Investigators; PHOENIX 2 Investigators; ACCEPT Investigators. Long-term safety of ustekinumab in patients with moderate-to-severe psoriasis: final results from 5 years of follow-up. Br J Dermatol. 2013;168(4):844–54.

    Article  CAS  PubMed  Google Scholar 

  • Plötz SG, Wiesender M, Todorova A, Ring J. What is new in atopic dermatitis/eczema? Expert Opin Emerg Drugs. 2014;19:9–18.

    Article  CAS  Google Scholar 

  • Hönigsmann H. Phototherapy. J Invest Dermatol. 2013;133(E1):E18–20. doi:10.1038/skinbio.2013.180.

    Article  PubMed  Google Scholar 

  • Reitamo S. Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis. J Allergy Clin Immunol. 2001;107:445–8.

    Article  CAS  PubMed  Google Scholar 

  • Schauber J, Gallo RL. Antimicrobial peptides and the skin immune system. JACL. 2008;122:261–6.

    CAS  Google Scholar 

  • Reitamo S. European Tacrolimus Ointment Study Group: 0.1 % Tacrolimus ointment twice a day is an effective treatment for adults with moderate to severe atomic dermatitis. JEADV. 2003;17:180.

    Google Scholar 

  • van den Bogaard EH, Bergboer JG, Vonk-Bergers M, van Vlijmen-Willems IM, Hato SV, van der Valk PG, Schröder JM, Joosten I, Zeeuwen PL, Schalkwijk J. Coal tar induces AHR-dependent skin barrier repair in atopic dermatitis. J Clin Invest. 2013;123(2):917–27.

    PubMed  PubMed Central  Google Scholar 

  • Stuetz A, Grassberger M, Meingassner JG. Pimecrolimus (Elidel, SDZ ASM 981) preclinical pharmacologic profile and skin selectivity. Semin Cutan Med Surg. 2001;20:233–41.

    Article  CAS  PubMed  Google Scholar 

  • Eyerich S, Onken AT, Weidinger S, Franke A, Nasorri F, Pennino D, Grosber M, Pfab F, Schmidt-Weber CB, Mempel M, Hein R, Ring J, Cavani A, Eyerich K. Mutual antagonism of T cells causing psoriasis and atopic eczema. N Engl J Med. 2011;365(3):231–8.

    Article  CAS  PubMed  Google Scholar 

  • Larkö O, Swanbeck G. Is UVB treatment of psoriasis safe? A study of extensively UVB-treated psoriasis patients compared with a matched control group. Acta Derm Venereol. 1982;62(6):507–12.

    PubMed  Google Scholar 

  • Hannuksela-Svahn A, Pukkala E, Läärä E, Poikolainen K, Karvonen J. Psoriasis, its treatment, and cancer in a cohort of Finnish patients. J Invest Dermatol. 2000;114(3):587–90.

    Article  CAS  PubMed  Google Scholar 

  • Krönauer C, Eberlein-König B, Ring J, Behrendt H. Influence of UVB, UVA and UVA1 irradiation on histamine release from human basophils and mast cells in vitro in the presence and absence of antioxidants. Photochem Photobiol. 2003;77(5):531–4.

    Article  PubMed  Google Scholar 

  • Gelfand HH, Cinder JC, Grant SF, Soiffer M. Evaluation of histamine-gamma globulin (histaglobin) in the treatment of various allergic conditions. Ann Allergy. 1963;21:150–5.

    CAS  PubMed  Google Scholar 

  • Forman SB, Garrett AB. Success of omalizumab as monotherapy in adult atopic dermatitis: case report and discussion of the high-affinity immunoglobulin E receptor, FcepsilonRI. Cutis. 2007;80(1):38–40.

    PubMed  Google Scholar 

  • Vigo PG, Girgis KR, Pfuetze BL, Critchlow ME, Fisher J, Hussain I. Efficacy of anti-IgE therapy in patients with atopic dermatitis. J Am Acad Dermatol. 2006;55(1):168–70.

    Article  PubMed  Google Scholar 

  • Fuhrmann T, Smith N, Tausk F. Use of complementary and alternative medicine among adults with skin disease: updated results from a national survey. J Am Acad Dermatol. 2010;63(6):1000–5.

    Article  PubMed  Google Scholar 

  • Abeck D, Ring J, editors. Atopisches Ekzem im Kindesalter. Neurodermitis – das zeitgemäße Management. Darmstadt: Steinkopff; 2002.

    Google Scholar 

  • Akdis CA, Blaser K, Akdis M. Genes of tolerance. Allergy. 2004;59:897–913.

    Article  CAS  PubMed  Google Scholar 

  • Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, Hamid Q, Kapp A, Leung DY, Lipozencic J, Luger TA, Muraro A, Novak N, Platts-Mills TA, Rosenwasser L, Scheynius A, Simons FE, Spergel J, Turjanmaa K, Wahn U, Weidinger S, Werfel T, Zuberbier T, European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. J Allergy Clin Immunol. 2006;118(1):152–69. Review. Erratum J Allergy Clin Immunol 2006;118(3):724.

    Article  PubMed  Google Scholar 

  • Alm JS, Swartz J, Lilja G, Scheynius A, Pershagen G. Atopy in children of families with an anthroposophic lifestyle. Lancet. 1999;353:1485–8.

    Article  CAS  PubMed  Google Scholar 

  • Arellano FM, Wentoworth CE, Arana A, Fernandez C, Paul CF. Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. J Invest Dermatol. 2007;127(4):808–16.

    Article  CAS  PubMed  Google Scholar 

  • Armstrong NC, Ernst E. The treatment of eczema with Chinese herbs: a systematic review of randomized clinical trials. Br J Clin Pharmacol. 1999;48:262–4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Artik S, Ruzicka T. Complementary therapy for atopic eczema and other allergic skin diseases. Dermatol Ther. 2003;16:150–63.

    Article  PubMed  Google Scholar 

  • Augustin M, Mrowietz U, Bonnekoh B, et al. Topical long-term therapy with vitamin D3 analogues, corticosteroids and their two compound formulations. JDDG. 2014;12:667–82.

    Google Scholar 

  • Augustin M, Zschocke I, Buhrke U. Attitudes and prior experience with respect to alternative medicine among dermatological patients: the Freiburg questionnaire on attitudes to naturopathy (FAN). Forsch Komplementarmed. 1999a;6:26–9.

    Article  PubMed  Google Scholar 

  • Beck J. Praxis der kognitiven Therapie. Weinheim: Psychologische Verlags Union; 1999.

    Google Scholar 

  • Bedi M, Shenefelt P. Herbal therapy in dermatology. Arch Dermatol. 2002;138:232–42.

    PubMed  Google Scholar 

  • Behrendt H, Ring J. Histamine, antihistamines and atopic eczema. Clin Exp Allergy. 1990;20 Suppl 4:25–30.

    Article  PubMed  Google Scholar 

  • Belloni B, Ziai M, Lim A, Lemercier B, Sbornik M, Weidinger S, Andres C, Schnopp C, Ring J, Hein R, Ollert M, Mempel M. Low-dose anti-IgE therapy in patients with atopic eczema with high serum IgE levels. J Allergy Clin Immunol. 2007;120:1223–5.

    Article  CAS  PubMed  Google Scholar 

  • Benez A, Fierlbeck G. Successful long-term treatment of severe atopic dermatitis with mycophe-nolatemofetil. Br J Dermatol. 2001;144(3):638–9.

    Article  CAS  PubMed  Google Scholar 

  • Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 1993;341:1557–60.

    Article  CAS  PubMed  Google Scholar 

  • Berth-Jones J, Damstra RJ, Golsch S, Livden JK, Van Hooteghem O, Allegra F, Parker CA. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis randomized double blind, parallel group study. BMJ. 2003;326:1367.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Bharati A, Yesudian PD. Positivity of iron studies in pruritus of unknown origin. J Eur Acad Dermatol Venereol. 2008;22:616–8.

    Article  Google Scholar 

  • Bieber T, Ring J. Terfenadin und Kraftfahrzeugführung. Eine placebokontrollierte Doppelblindstudie zum Einfluss verschiedener Antihistaminika auf das Fahrverhalten. Med Klin. 1987;82:683–6.

    CAS  Google Scholar 

  • Bode HH. Dwarfism following long-term topical corticosteroid therapy. JAMA. 1980;244:813–4.

    Article  CAS  PubMed  Google Scholar 

  • Boguniewicz M, Sampson H, Leung SB, Harbeck R, Leung DYM. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. J Allergy Clin Immunol. 2001;108(4):651–2.

    Article  CAS  PubMed  Google Scholar 

  • Bornhoevd EC, Schuller E, Bieber T, Wollenberg A. Immunsuppressive Makrolide und ihr Einsatz in der Dermatologie. Hautarzt. 2000;51:646–54.

    Article  Google Scholar 

  • Bourke JF, Berth-Jones J, Holder J, Graham-Brown RA. A new microemulsion formulation of cyclo-sporin (Neoral) is effective in the treatment of cyclosporin-resistant dermatoses. Br J Dermatol. 1996;134:777–9.

    Article  CAS  PubMed  Google Scholar 

  • Bresser H. Allergietestung mittels Elektroakupunktur nach Dr. Voll Hautarzt. 1993;46:408–9.

    Google Scholar 

  • Broberg A, Faergemann J. Topical antimycotic treatment of atopic dermatitis in the head/neck area. A double-blind randomized study. Acta Derm Venereol. 1995;75:46–9.

    CAS  PubMed  Google Scholar 

  • Brockow K, Grabenhorst P, Abeck D, et al. Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema. Dermatology. 1999b;199:231–6.

    Article  CAS  PubMed  Google Scholar 

  • Buddenkotte J, Steinhoff M. Pathophysiology and therapy of pruritus in allergic and atopic diseases. Allergy. 2010;65:805–21.

    Article  CAS  PubMed  Google Scholar 

  • Bunikowski R, Staab D, Kussebi F, Brautigam M, Weidinger G, Renz H, Wahn U. Low-dose cyclospor-in A microemulsion in children with severe atopic dermatitis: clinical and immunological effects. Pediatr Allergy Immunol. 2001;12:216–23.

    Article  CAS  PubMed  Google Scholar 

  • Buslau M, Thaci D. Atopic dermatitis: borage oil for systemic therapy. Z Dermatol. 1996;182:131–6.

    Google Scholar 

  • Bussmann C, Böckenhoff A, Henke H, Werfel T, Novak N. Does allergen-specific immunotherapy represent a therapeutic option for patients with atopic dermatitis? J Allergy Clin Immunol. 2006;118:1292–8.

    Article  CAS  PubMed  Google Scholar 

  • Cap F. Bemerkungen eines Physikers zur Bioresonanz. Allergologie. 1995;18:235–7.

    Google Scholar 

  • Carlsson CP, Wallengren J. Therapeutical and experimental therapeutic studies on acupuncture and itch: review of the literature. J Eur Acad Dermatol Venereol. 2010;24:1013–6.

    CAS  PubMed  Google Scholar 

  • Cap F. Bemerkungen eines Physikers zur Bioresonanz. Allergologie. 1995;18:235–7.

    Google Scholar 

  • Cheng H-M, Chiang L-C, Jan Y-M, Chen G-W. The efficacy and safety of a Chinese herbal product (Xiao-Feng-San) for the treatment of refractory atopic dermatitis: a randomized, double-blind, placebo-controlled trial. Int Arch Allergy Immunol. 2011;155:141–8.

    Article  PubMed  Google Scholar 

  • Christiansen JV, Gadborg E, Kleiter I, et al. Efficacy of bufexamac cream in skin diseases. A double-blind multicentre trial. Dermatologica. 1977;154:177–84.

    Article  CAS  PubMed  Google Scholar 

  • Cox L, Platts-Mills TA, Finegold I et al. American Academy of Allergy, Asthma & Immunolo-gy/American College of Allergy, Asthma and Immunology Joint Task Force. Report on omalizumab-associated anaphylaxis. J Allergy Clin Immunol. 2007;120:1373–7.

    Google Scholar 

  • Colcha W, Leuschner J, Leuschner F. The adverse effects of dark sulfonated shale oil following local and systemic administration. Arzneimittelforschung. 1994;44:844–9.

    Google Scholar 

  • Czarnecka-Operacz M, Silny W. Specific immunotherapy in atopic dermatitis – four-year treatment in different age and airborne allergy type subgroups. Acta Dermatovenerol Croat. 2006;14(4):230–40.

    PubMed  Google Scholar 

  • Dale HH, Laidlaw BP. The physiological action of β-Imidazolylethylamine. J Physiol. 1910;41:318.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Dale HH, Laidlaw BP. The physiological action of β-Imidazolylethylamine. J Physiol. 1910;41:318.

    Google Scholar 

  • Darsow U, Mautner VF, Bromm B, Scharein E, Ring J. Der Eppendorfer Juckreizfragebogen. Hautarzt. 1997a;48:730–3.

    Article  CAS  PubMed  Google Scholar 

  • Darsow U, Scharein E, Bromm B, Ring J. Skin testing of the pruritogenic activity of histamine and cytokines (interleukin-2 and tumor necrosis factor-alpha) at the dermal-epidermal junction. Br J Dermatol. 1997b;137:415–7.

    Article  CAS  PubMed  Google Scholar 

  • Darsow U, Drzezga A, Frisch M, Munz F, Weilke F, Bartenstein P, Schwaiger M, Ring J. Processing of histamine-induced itch in the human cerebral cortex: a correlation analysis with dermal reactions. Soc Invest Dermatol. 2000;115:1029–33.

    Article  CAS  Google Scholar 

  • Darsow U, Forer I, Ring J. Spezifische Hyposensibilisierung bei atopischem Ekzem. Allergologie. 2005;28:53–61.

    Article  Google Scholar 

  • Darsow U, Wollenberg A, Simon D, Taïeb A, Werfel T, Oranje A, Gelmetti C, Svensson A, Deleuran M, Calza A-M, Giusti F, Lübbe J, Seidenari S, Ring J. ETFAD/EADV eczema task force 2009 position paper on diagnosis and treatment of atopic dermatitis. J Eur Acad Dermatol Venereol. 2010;24:317–28.

    Article  CAS  PubMed  Google Scholar 

  • Desai NS, Poindexter GB, Monthrope YM, Bendeck SE, Swerlick RA, Chen SC. A pilot quality-of-life instrument for pruritus. J Am Acad Dermatol. 2008;59(2):234–44. doi:10.1016/j.jaad.2008.04.006. Epub 11 June 2008.

    Article  PubMed  Google Scholar 

  • Devillers ACA, de Waard-van der Spek FB, Mulder PGH, Oranje AP. Treatment of refractory atopic dermatitis using “wet-wrap” dressings and diluted corticosteroids: results of standardized treat-ment in both children and adults. Dermatology. 2002;204:50–5.

    Article  CAS  PubMed  Google Scholar 

  • Diezel W, Gruner S, Anhalt GJ. ATPase positive epidermal Langerhans cells: inhibition of ATPase by ammonium bituminosulfonate (Ichthyol) and pix lithanthracis. Hautarzt. 1992;43:22–4.

    CAS  PubMed  Google Scholar 

  • Dorsch W, Ring J. Komplementärverfahren oder sogenannte Alternativmethoden in der Allergologie. Allergo J. 2002;11:163–70.

    Google Scholar 

  • Dorsch W, Sitzmann FC, editors. Naturheilkunde in der Kinderheilkunde. 2nd ed. Stuttgart: Hippokrates; 2001.

    Google Scholar 

  • Eberlein B, Gulyas AF, Schultz K, Lecheler J, Flögel S, Wolfmeyer C, Thiessen K, Jakob T, Schuster T, Hollweck R, Ring J, Behrendt H. Domestic allergens and endotoxin in three hospitals offering in-patient rehabilitation for allergic disease in the alpine mountain climate of Bavaria – The AURA study. Int J Hyg Environ Health. 2009b;212:21–6.

    Article  CAS  PubMed  Google Scholar 

  • Egle UT, König U, Dorsch W. Zur pathogenetischen Bedeutung früher psychosozialer Einflussfaktoren bei atopischer Dermatitis. Allergologie. 2002;25:291–9.

    Article  Google Scholar 

  • Ehlers A, Stangier U, Gieler U. Treatment of atopic dermatitis. A comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol. 1995;63:624–35.

    Article  CAS  PubMed  Google Scholar 

  • Eichenfield LF, Lucky AW, Boguniewicz M, Langley RG, Cherill R, Marshall K, Bush C, Graeber M. Safety and efficacy of pimecrolimus (ASM 981) cream 1 % in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol. 2002;46(4):495–504.

    Article  PubMed  Google Scholar 

  • Elman S, Hynan LS, Gabriel V, Mayo MJ. The 5-D itch scale: a new measure of pruritus. Br J Dermatol. 2010;162:587–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Engman MF, Weiss RS, Engman ME. Eczema and environment. Med Clin North Am. 1936;20:651–63.

    Google Scholar 

  • Engst R, Vocks E. Hochgebirgsklimatherapie bei Dermatosen und Allergien. Wirkmechanismen, Ergebnisse und Einflüsse auf immunologische Parameter. Rehabilitation. 2000;39:215–22.

    Article  CAS  PubMed  Google Scholar 

  • Ernst E, Barnes J. Are homeopathic remedies effective for delayed-onset muscle soreness? A systemic review of placebo-controlled trials. Perfusion. 1998;11:4–8.

    Google Scholar 

  • Ewing CI, Ashcroft C, Gibbs AC, Jones GA, Connor PJ, David TJ. Flucloxacilin in the treatment of atopic dermatitis. Br J Dermatol. 1998;138:1022–9.

    Article  CAS  PubMed  Google Scholar 

  • Falk ES. Ketotifen in the treatment of atopic dermatitis. Results of a double-blind study. Rev Eur Sci Med Farmacol. 1993;15(2):63–6.

    CAS  Google Scholar 

  • Ferguson JE, Chalmers RJ, Rowlands DJ. Reversible dilated cardiomyopathy following treatment of atopic eczema with Chinese herbal medicine. Br J Dermatol. 1997;136:592–3.

    Article  CAS  PubMed  Google Scholar 

  • Fölster-Holst R, Pape M, Buss YL, et al. Low prevalence of the intrinsic form of atopic dermatitis among adult patients. Allergy. 2006b;61:629–33.

    Article  PubMed  Google Scholar 

  • Freitag G, Hoppner T. Results of a postmarketing drug monitoring survey with a polidocanol-urea preparation for dry, itching skin. Curr Med Res Opin. 1997;13:529–37.

    Article  CAS  PubMed  Google Scholar 

  • Frosch PJ, Schwanitz HJ, Macher E. A double blind trial of h1 and h2 receptor antagonists in the treatment of atopic dermatitis. Arch Dermatol Res. 1984;276(1):36–40.

    Article  CAS  PubMed  Google Scholar 

  • Furue M, Terao H, Rikihisa W, Urabe K, Kinukawa N, Nose Y, Koga T. Clinical dose and adverse effects of topical steroids in daily management of atopic dermatitis. Br J Dermatol. 2003;148(1):128–33.

    Article  CAS  PubMed  Google Scholar 

  • Gauger A, Mempel M, Schekatz A, Schäfer T, Ring J, Abeck D. Silver-coated textiles reduce Staphylococcus aureus colonization in patients with atopic eczema. Dermatology. 2003;207:15–21.

    Article  PubMed  Google Scholar 

  • Gauger A, Fischer S, Mempel M, Schaefer T, Foelster-Holst R, Abeck D, Ring J. Efficacy and func-tionality of silver-coated textiles in patients with atopic eczema. J Eur Acad Dermatol Venereol. 2006;20(5):534–41. Erratum J Eur Acad Dermatol Venereol. 2006;20(6):771.

    Google Scholar 

  • Gibbs NK, Norval M. Photoimmunosuppression: a brief overview. Photodermatol Photoimmunol Photomed. 2013;29:57–64.

    Article  CAS  PubMed  Google Scholar 

  • Gläser R, Navid F, Schuller W, Jantschitsch C, Harder J, Schröder J, Schwarz A, Schwarz T. UV-B radiation induces the expression of antimicrobial peptides in human keratinocytes in vitro and in vivo. J Allergy Clin Immunol. 2009b;123:1117–23.

    Article  PubMed  CAS  Google Scholar 

  • Grewe M. Hyposensibilisierung bei atopischem Ekzem. Allergo J. 2000;9:351–351.

    Google Scholar 

  • Grundmann-Kollmann M, Korting HC, Behrens S, et al. Successful treatment of severe refractory atopic dermatitis with myccophenolate mofetil. Br J Dermatol. 1999;141:175–6.

    Article  CAS  PubMed  Google Scholar 

  • Gutzmer R, Langer K, Lisewski M, Mommert S, Rieckborn D, Kapp A, Werfel T. Expression of a function of histamine receptors 1 and 2 on human monocyte-derived dendritic cells. J Allergy Clin Immunol. 2002;109:524.

    Article  CAS  PubMed  Google Scholar 

  • Gutzmer R, Mommert S, Gschwandtner M, Zwingmann K, Stark H, Werfel T. The histamine H4 recep-tor is functionally expressed on T(H)2 cells. J Allergy Clin Immunol. 2009;123:619–25.

    Article  CAS  PubMed  Google Scholar 

  • Haeck IM, Knol MJ, ten Berge O, van Velsen SGA, de Bruin-Weller MS, Bruijnzeel-Koomen CAFM. Enteric-coated mycophenolate sodium versus cyclosporin A as long-term treatment in adult patients with severe atopic dermatitis: a randomized controlled trial. J Am Acad Dermatol. 2011a;64:1074–84.

    Article  CAS  PubMed  Google Scholar 

  • Haeck IM, Rouwen TJ, Timmer-de Mik L, de Bruin-Weller MS, Bruijnzeel-Koomen CA. Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts. J Am Acad Dermatol. 2011b;64:275–81.

    Article  CAS  PubMed  Google Scholar 

  • Hahnemann S. Die chronischen Krankheiten, ihre eigentümliche Natur und homöopathische Heilung. Leipzig: Hauk; 1835.

    Google Scholar 

  • Hanifin J, Gupta AK, Rajagopalan R. Intermittent dosing of fluticasone propionate cream for reducing the risk of relapse in atopic dermatitis patients. Br J Dermatol. 2002;147:528–37.

    Article  CAS  PubMed  Google Scholar 

  • Hannuksela M, Karvonen J, Husa M, Jokela R, Katajamäki L, Leppisaari M. Ultraviolet light therapy in atopic dermatitis. Acta Derm Venereol. 1985;114:137–9.

    CAS  Google Scholar 

  • Hannuksela M, Kalimo K, Lammintausta K, et al. Dose ranging study: cetirizine in the treatment of atopic dermatitis in adults. Ann Allergy. 1993;70:127–33.

    CAS  PubMed  Google Scholar 

  • Hansen ER, Buus S, Deleuran M, Andersen KE. Treatment of atopic dermatitis with mycophenolate mofetil. Br J Dermatol. 2000;143(6):1324–6.

    Article  CAS  PubMed  Google Scholar 

  • Happle R. The essence of alternative medicine. A dermatologist’s view from Germany. Arch Dermatol. 1998;134:1455–60.

    CAS  PubMed  Google Scholar 

  • Harari M, Shani J, Seidl V, Hristakieva E. Climatotherapy of atopic dermatitis at the Dead Sea: demo-graphic evaluation and cost-effectiveness. Int J Dermatol. 2000;39(1):59–69.

    Article  CAS  PubMed  Google Scholar 

  • Harper JI, Ahmed I, Barclay G, et al. Cyclosporin for severe childhood atopic dermatitis: short course versus continuous therapy. Br J Dermatol. 2000;142:52–8.

    Article  CAS  PubMed  Google Scholar 

  • Harper J, Oranje A, Prose N, editors. Textbook of pediatric dermatology. Oxford: Blackwell; 2002.

    Google Scholar 

  • Hatz HJ. Glucocorticoide. Immunologische Grundlagen, Pharmakologie und Therapierichtlinien. 1st ed. Stuttgart: Wissenschaftliche Verlagsgesellschaft mbH; 1998.

    Google Scholar 

  • Hausen BM, Vieluf IK. Allergiepflanzen – Pflanzenallergene. Ecomed: Landsberg; 1997.

    Google Scholar 

  • Hauss H, Proppe A, Matthies C. Vergleichende Untersuchungen zu Behandlung von trockener, ju-ckender Haut mit einer Zubreitung aus Harnstoff und Polidocanol sowie mit einer Linolsäure-haltigen Fettcreme. Ergebnisse aus der Praxis. Dermatosen Beruf Umwelt. 1993;41(5):184–8.

    Google Scholar 

  • Hindley D, Galloway G, Murray J, Gardener L. A randomised study of “wet wraps” versus conventional treatment for atopic eczema. Arch Dis Child. 2006;91(2):164–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hoare C, Li Wan Po A, Williams H. Systematic review of treatments for atopic eczema. Health Technol Assess. 2000;4:1–191.

    CAS  PubMed  Google Scholar 

  • Holgate S, Casale T, Wenzel S, Bousquet J, Deniz Y, Reisner C. The anti-inflammatory effects of omalizumab confirm the central role of IgE in allergic inflammation. J Allergy Clin Immunol. 2005;115:459–65.

    Article  CAS  PubMed  Google Scholar 

  • Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol. 2006;118:178–89.

    Article  CAS  PubMed  Google Scholar 

  • Homey B, Steinhoff M, Ruzicka T, Leung DY. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol. 2006;118:178–89.

    Google Scholar 

  • Iikura Y, Naspitz CK, Mikawa H, Talaricoficho S, Baba M, Sole D, Nishima S. Prevention of asthma by ketotifen in infants with atopic dermatitis. Ann Allergy. 1992;68:233–6.

    CAS  PubMed  Google Scholar 

  • Isolauri E, Arvola T, Sütas Y, Moilanen E, Salminen S. Probiotics in the management of atopic eczema. Clin Exp Allergy. 2000;30:1604–10.

    Article  CAS  PubMed  Google Scholar 

  • Jacobi A, Antoni C, Manger B, Schuler G, Hertl M. Infliximab in the treatment of moderate to severe atopic dermatitis. J Am Acad Dermatol. 2005;52:522–6.

    Article  PubMed  Google Scholar 

  • Jacobsen E. Progressive relaxation. Chicago: University Press; 1938.

    Google Scholar 

  • James JM, Burks AW, Roberson PK, Sampson HA. Safe administration of the measles vaccine to children allergic to eggs. N Engl J Med. 1995;332:1262–6.

    Article  CAS  PubMed  Google Scholar 

  • Jekeler J, Larkö O. Phototherapy for atopic dermatitis with ultraviolet A (UVA), low dose UVB and combined UVA and UVB: two paired comparison studies. Photodermatol Photoimmunol Photomed. 1991;8:151–6.

    Google Scholar 

  • Kalliomäki M, Salminen S, Arvilommi H, Kero P, Koskinen P, Isolauri E. Probiotics in primary prevention of atopic disease: a randomized placebo-controlled trial. Lancet. 2001;357:1076–9.

    Article  PubMed  Google Scholar 

  • Kapp A, Papp K, Bingham A, Fölster-Holst R, Ortonne JP, Potter PC, Gulliver W, Paul C, Molloy S, Barbier N, Thurston M, de Prost Y, for the Flare Reduction in Ekzema with Elidel (Infants) Multicenter Investigator Study Group. Long-term management of atopic dermatitis in infants with topical pimecrolimus, a nonsteroid anti-inflammatory drug. J Allergy Clin Immunol. 2002;110:277–84.

    Article  CAS  PubMed  Google Scholar 

  • Katagiri K, Arakawa S, Hatano Y, Fujiwara S. Tolerogenic antigen-presenting cells successfully inhibit atopic dermatitis-like skin lesion induced by repeated epicutaneous exposure to ovalbumin. Arch Dermatol Res. 2008;300:583–93.

    Article  CAS  PubMed  Google Scholar 

  • Kawashima M, Tango T, Noguchi T, Inagi M, Nakagawa H, Harada S. Addition of fexofenadine to a topical corticosteroid reduces the pruritus associated with atopic dermatitis in a 1-week randomized, multicentre, double-blind, placebo-controlled, parallel-group study. Br J Dermatol. 2003;148:1212–21.

    Article  CAS  PubMed  Google Scholar 

  • Kleijnen J, Kniepschild P, ter Riet G. Clinical trials in homoepathy. Br Med J. 1991;302:316–23.

    Article  CAS  Google Scholar 

  • Kneipp S. Meine Wasser-Kur. 50th ed. Kempten: Kösel’sche Buchhandlung; 1984.

    Google Scholar 

  • Klein PA, Clark RA. An evidence-based review of the efficacy of antihistamines in relieving pruritus in atopic dermatitis. Arch Dermatol. 1999;135:1522–5.

    Google Scholar 

  • Knobler RM. Photophoresis – extracorporal irradiation of 8-MOP containing blood – a new therapeutic modality. Blood. 1987;54:247–50.

    CAS  Google Scholar 

  • Kofler H, Ulmer H, Mechter E, Falk M, Fritsch PO. Bioresonanz bei Pollinose: Eine vergleichende Un-tersuchung zur diagnostischen und therapeutischen Wertigkeit. Allergologie. 1996;19:114–22.

    Google Scholar 

  • Korting HC. Äußerliche Dermatotherapie. In: Braun-Falco O, Plewig G, Wolff HH, editors. Dermatologie und Venerologie. 4th ed. Berlin: Springer; 1995. p. 1488–529.

    Google Scholar 

  • Kowalzick L, Kleinheinz A, Weichenthal M, Ring J. Low-dose versus medium-dose UVA1 treatment in severe atopic eczema. Acta Derm Venereol. 1995;75:43–5.

    CAS  PubMed  Google Scholar 

  • Krutmann J, Hönigsmann H. Handbuch der dermatologischen Phototherapie und Photodiagnostik. Berlin/Heidelberg: Springer; 1997.

    Book  Google Scholar 

  • Krutmann J, Czech W, Diepgen T, Niedner R, Kapp A, Schopf E. Highdose UVA-1 therapy in the trea-tment of patients with atopic dermatitis. J Am Acad Dermatol. 1992;26:225–30.

    Article  CAS  PubMed  Google Scholar 

  • Kukutsch NA. Darstellung und Diskussion alternativer/komplementärer diagnostischer und/oder the-rapeutischer Konzepte im Hinblick auf atopische Erkrankungen. Dissertation, Universität Hamburg, 1997

    Google Scholar 

  • Kunz B, Lüdtke R, Leeber N, Ring J. Test-retest-reliability and validity of the kinesiology muscle test. Complement Ther Med. 2001;9:141–5.

    Article  PubMed  Google Scholar 

  • Kwiek B, Novak N. Immunosupressants as treatment for atopic dermatitis. In: Pawankar R et al., editors. Allergy frontiers: therapy and prevention. Berlin/New York: Springer; 2010. p. 291–310.

    Google Scholar 

  • La Rosa M, Ranno C, Musarra I, Guglielmo F, Corrias A, Bellanti JA. Double-blind study of cetirizine in atopic eczema in children. Ann Allergy. 1994;73(2):117–22.

    PubMed  Google Scholar 

  • Langeland T, Fagertum HE, Larsen S. Therapeutic effect of loratadine on pruritus in patients with atopic dermatitis. A multi-crossover-designed study. Allergy. 1994;49(1):22–6.

    Article  CAS  PubMed  Google Scholar 

  • Langer H, Hauswald B. Langzeitstudie über die Therapie der Rhinopathia pollinosa mittels Akupunktur bzw. Laserakupunktur Erfahrungsheilkunde. 1992;4:262–7.

    Google Scholar 

  • Leung DY. Infection in atopic dermatitis. Curr Opin Pediatr. 2003;15:399–404.

    Article  PubMed  Google Scholar 

  • Leung DY, Hirsch RL, Schneider L, et al. Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol. 1990;85:927–33.

    Article  CAS  PubMed  Google Scholar 

  • Leung DY, Sampson HA, Yunginger JW, Burks Jr AW, Schneider LC, Wortel CH, Davis FM, Hyun JD, Shanahan Jr WR. Effect of anti-IgE therapy in patients with peanut allergy. N Engl J Med. 2003;348:986.

    Article  CAS  PubMed  Google Scholar 

  • Lever R, Hadley K, Downey D, Mackie R. Staphylococcal colonization in atopic dermatitis and the effect of topical mupirocin therapy. Br J Dermatol. 1988;119:189–98.

    Article  CAS  PubMed  Google Scholar 

  • Lim A, Luderschmidt S, Weidinger A, Schnopp C, Ring J, Hein R, Ollert M, Mempel M. The IgE repertoire in PB-MCs of atopic patients is characterized by individual rearrangements without variable region of the heavy immunoglobulin chain bias. J Allergy Clin Immunol. 2007;120:696–706.

    Article  CAS  PubMed  Google Scholar 

  • Lord GM. Nephropathy caused by Chinese herbs in the UK. Lancet. 1999;354:481–2.

    Article  CAS  PubMed  Google Scholar 

  • Lubbe J. Klinische Erfahrungen mit topischen Calcineurininhibitoren in der Praxis. Hautarzt. 2003;54(5):432–9.

    CAS  PubMed  Google Scholar 

  • Luger TA. Balancing efficacy and safety in the management of atopic dermatitis: the role of methylprednisolone aceponate. J Eur Acad Dermatol Venereol. 2010;25:251–8.

    Article  CAS  Google Scholar 

  • Luger T, Loske K, Elsner P, et al. Topical skin therapy with glucocorticosteroids – therapeutic index. J Dtsch Dermatol Ges. 2004;7:629–34.

    Google Scholar 

  • Luger TA, Bieber T, Meurer M, et al. Therapie des atopischen Ekzems mit Calcineurin-Inhibitoren. Leit-linie der Deutschen Dermatologischen Gesellschaft. J Dtsch Dermatol Ges. 2005;3:385–91.

    PubMed  Google Scholar 

  • Lyakhovitsky A, Barzilai A, Heyman R, Baum S, Amichai B, Solomon M, Shpiro D, Trau H. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults. J Eur Acad Dermatol Venereol. 2010;24:43–9.

    Article  CAS  PubMed  Google Scholar 

  • Manenti L, Vaglio A. Gabapentin for uraemic pruritus. Nephrol Dial Transpl. 2005;20:1278–9.

    Article  Google Scholar 

  • Mayaux MJ, Guihard-Moscato ML, Schwartz D, Benveniste J, Coquin Y, Crapanne JB, Poiterin B, Rodary M, Chevrel JP, Mollet M. Controlled clinical trial of homoeopathy in postoperative ileus. Lancet. 1988;8584:528–9.

    Article  Google Scholar 

  • Mayser P, Kupfer J, Nemetz D, Schäfer U, Nilles M, Hort W, Gieler U. Treatment of head and neck dermatitis with ciclopiroxolamine cream – results of a double-blind, placebo-controlled study. Skin Pharmacol Physiol. 2006;19(3):153–9.

    Article  CAS  PubMed  Google Scholar 

  • Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet. 2006;367(9513):839–46.

    Article  CAS  PubMed  Google Scholar 

  • Meingassner JG, Grassberger M, Fahrngruber H, Moore HD, Schuurman H, Stutz A. A novel anti-inflammatory drug, SDZ ASM 981, for the topical and oral treatment of skin diseases: in vivo pharmacology. Br J Dermatol. 1997;137:568–76.

    Article  CAS  PubMed  Google Scholar 

  • Melin L, Frederiksen T, Noren P, Swebilius BG. Behavioural treatment of scratching in patients with atopic dermatitis. Br J Dermatol. 1986;115(4):467–74.

    Article  CAS  PubMed  Google Scholar 

  • Meurer M, Fölster-Holst R, Wozel G, Weidinger G, Junger M, Bräutigam M. CASM-DE-01 study group: Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in adults: a six-month study. Dermatology. 2002;205:271–7.

    Article  CAS  PubMed  Google Scholar 

  • Meurer M, Fartasch M, Albrecht G, et al. Long-term efficacy and safety of pimecrolimus cream 1 % in adults with moderate atopic dermatitis. Dermatology. 2004;208:365–72.

    Article  PubMed  Google Scholar 

  • Milingou M, Antille C, Sorg O, Saurat JH, Lubbe J. Alcohol intolerance and facial flushing in patients treated with topical tacrolimus. Arch Dermatol. 2004;140(12):1542–4.

    PubMed  Google Scholar 

  • Mostafa-Kara N, Pauwels A, Pinus E, Biuor M, Levy VG. Fatal hepatitis after herbal tea. Lancet. 1992;340:674.

    Article  Google Scholar 

  • Munkvad M. A comparative trial of Clinitar versus hydrocortisone cream in the treatment of atopic eczema. Br J Dermatol. 1989;121:763–6.

    Article  CAS  PubMed  Google Scholar 

  • Murota H, Kitaba S, Tani M, Wataya-Kaneda M, Azukizawa H, Tanemura A, Umegaki N, Terao M, Kotobuki Y, Katayama I. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int. 2010;59:345–54.

    Article  PubMed  Google Scholar 

  • Murphy LA, Atherton DJ. A retrospective evaluation of azathioprine in severe childhood atopic eczema, using thiopurine methyl transferase levels to exclude patients at high risk of myelosuppression. Br J Dermatol. 2002;147:324–30.

    Article  Google Scholar 

  • Nahm D-H, Lee ES, Park H-J, Kim H-A. Treatment of atopic dermatitis with a combination of allergen-specific immunotherapy and a histamine-immunoglobulin complex. Int Arch Allergy. 2008;146:235–40.

    Article  CAS  Google Scholar 

  • Nakano T, Shimojo N, Okamoto Y, Ebisawa M, Kurihara K, Hoshioka A, Yamaguchi K, Ito K, Fujisawa T, Kameda M, Suehiro Y, Ogura H, Shibata R, Suzuki S, Takahashi Y, Ikeda M, Kohno Y. The use of complementary and alternative medicine by pediatric food-allergic patients in Japan. Int Arch Allergy Immunol. 2012;159:410–5.

    Article  PubMed  Google Scholar 

  • Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol. 2000;143:385–91.

    Article  CAS  PubMed  Google Scholar 

  • Niebel G. Verhaltensmedizinisches Gruppentraining für Patienten mit atopischer Dermatitis in Ergän-zung zur dermatologischen Behandlung; Pilotstudie zur Erprobung von Selbsthilfestrategien. Verhaltenmodifikation und Verhaltensmedizin. 1990;11:24–44.

    Google Scholar 

  • Niebel G. Verhaltensmedizin der chronischen Hautkrankheiten. Huber Verlag: Bern; 1995.

    Google Scholar 

  • Novak N, Bieber T, Hoffmann M, Fölster-Holst R, Homey B, Werfel T, Sager A, Zuberbier T. Efficacy and safety of subcutaneous allergen-specific immunotherapy with depigmented polymerized mite extract in atopic dermatitis. J Allergy Clin Immunol. 2012;130:925–31.

    Article  CAS  PubMed  Google Scholar 

  • O’Driscoll J, Burden AD, Kingston TP. Potent topical steroid obtained from a Chinese herbalist. Br J Dermatol. 1992;127:543–4.

    Article  PubMed  Google Scholar 

  • Oepen J. Unkonventionelle diagnostische und therapeutische Methoden in der Umweltmedizin. Gesundheitswesen. 1998;60:420–30.

    CAS  PubMed  Google Scholar 

  • Oldhoff JM, Darsow U, Werfel T, Katzer K, Wulf A, Laifaoui J, Hijnen DJ, Plotz S, Knol EF, Kapp A, Bruijnzeel-Koomen CA, Ring J, de Bruin-Weller MS. Anti-IL-5 recombinant humanized monoclonal antibody (mepolizumab) for the treatment of atopic dermatitis. Allergy. 2005;60:693–6.

    Article  CAS  PubMed  Google Scholar 

  • Pajno GB, Vita D, Barberio E, Salzano G, Lombardo F, et al. Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind placebo-controlled study. J Allergy Clin Immunol. 2007;120:164–70.

    Article  CAS  PubMed  Google Scholar 

  • Paller A, Eichenfield LF, Leung DY, et al. A 12-week study of tacrolimus ointment for the treatment of atopic dermatitis in pediatric patients. J Am Acad Dermatol. 2001;44:S47–57.

    Article  CAS  PubMed  Google Scholar 

  • Paller AS, Lebwohl M, Fleischer AB, Antaya R, Langley RG, Kirsner RS, Blum RR, Rico MJ, Jaracz E, Crowe A, et al. Tacrolimus ointment is more effective than pimecrolimus cream with a similar safety profile in the treatment of atopic dermatitis: results from 3 randomized comparative studies. J Am Acad Dermatol. 2005;52:810–22.

    Article  PubMed  Google Scholar 

  • Papoiu ADP, Wang H, Coghill RC, Chan Y-H, Yosipovitch G. Contagious itch in humans: a study of visual “transmission” of itch in atopic dermatitis and healthy subjects. Br J Dermatol. 2011;164:1299–303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Paul C, Lahfa M, Bachelez H, Chevret S, Dubertret L. A randomized controlled evaluator-blinded trial of intravenous immunoglobulin in adults with severe atopic dermatitis. Br J Dermatol. 2002;147:518–22.

    Article  CAS  PubMed  Google Scholar 

  • Peserico A, Stadtler G, Sebastian M, Fernandez RS, Vick K, Bieber T. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double-blind, controlled study. Br J Dermatol. 2008;158:801–7.

    Article  CAS  PubMed  Google Scholar 

  • Pfab F, Huss-Marp J, Gatti A, Fuqin J, Athanasiadis GI, Irnich D, Raap U, Schober W, Behrendt H, Ring J, Darsow U. Influence of acupuncture on type I hypersensitivity itch and the wheal and flare response in adults with atopic eczema – a blinded, randomized, placebo-controlled, crossover trial. Allergy. 2010a;66:903–10.

    Google Scholar 

  • Pfab F, Valet M, Sprenger T, Huss-Marp J, Athanasiadis GI, Baurecht HJ, Konstantinow A, Zimmer C, Behrendt H, Ring J, Tölle TR, Darsow U. Temperature-modulated histamine-itch in nonlesional skin in atopic eczema – a combined psychophysical and neuroimaging study. Allergy. 2010b;65:84–94.

    Article  CAS  PubMed  Google Scholar 

  • Pichler W, Bircher AA, Wüthrich B. Spezialistenkommission der Schweizer Gesellschaft für Allergolo-gie und Immunologie. Allergologie und Alternativmedizin. Stellungnahme zu paramedizinischen Verfahren, speziell Bioresonanz. Schweiz Ärztezeitung, nachgedruckt in. Allergologie. 1996;19:158–61.

    Google Scholar 

  • Pion IA, Koenig KL, Lim HW. Is dermatologic usage of coal tar carcinogenic? A review of the literature. Dermatol Surg. 1995;21:227–31.

    CAS  PubMed  Google Scholar 

  • Plötz SG, Simon HU, Darsow U, Simon D, Vassina E, Yousefi S, Hein R, Smith T, Behrendt H, Ring J. Use of anti-interleukin-5 antibody in hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med. 2003;349:2332–7.

    Article  Google Scholar 

  • Prinz B, Nachbar F, Plewig G. Treatment of severe atopic dermatitis with extracorporal photophoresis. Arch Dermatol Res. 1994;287:48–52.

    Article  CAS  PubMed  Google Scholar 

  • Prochazka B. Sensibilität und Abgrenzung bei Neurodermitikern. Wiesen: Porch; 1994.

    Google Scholar 

  • Purohit A, Duvernelle C, Melac M, Pauli G, Frossard N. Twenty-four hours of activity of cetirizine and fexofenadine in the skin. Ann Allergy Asthma Immunol. 2001;86:387–92.

    Article  CAS  PubMed  Google Scholar 

  • Ramsay CA, Savoie JM, Gilbert M, Gidon M, Kidson P. The treatment of atopic dermatitis with topical fusidic acid and hydrocortisone acetate. J Eur Acad Dermatol Venerol. 1996;7(Suppl I):15–22.

    Article  Google Scholar 

  • Reitamo S, Rissanen J, Remitz A, et al. Tacrolimus ointment does not affect collagen synthesis results of a single-center randomized trial. J Invest Dermatol. 1998;111:396–8.

    Article  CAS  PubMed  Google Scholar 

  • Reitamo S, Van Leent EJ, Ho V, Harper J, Ruzicka T, Kalimo K, Cambazard F, Rustin M, Taïeb A, Gratton D, Sauder D, Sharpe G, Smith C, Junger M, de Prost Y. Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol. 2002;109(3):539–46.

    Article  CAS  PubMed  Google Scholar 

  • Reitamo S, Ortonne JP, Sand C, et al. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1 % tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 2005;152:1282–9.

    Article  CAS  PubMed  Google Scholar 

  • Reitamo S, Ortonne JP, Sand C, Bos J, Cambazard F, Bieber T, Gronhoj-Larsen C, Rustin M, Fölster-Holst R, Schuttelaar M. Long-term treatment with 0.1 % tracrolimus ointment in adults with atopic der-matitis: results of a two-year, multicentre, non-comparative study. Acta Derm Venereol. 2007;87:406–12.

    Article  CAS  PubMed  Google Scholar 

  • Remy W, Rakoski J, Siebenwirth J, Ulm K, Wiesenauer M. Classical homeopathic treatment in atopic dermatitis. Allergologie. 1995;18:246–52.

    Google Scholar 

  • Reuter J, Wölfle U, Weckesser S, Schempp C. Which plant for which skin disease? Part 1: atopic dermatitis, psoriasis, acne, condyloma and herpes simplex. J Dtsch Dermatol Ges. 2010;8:788–96.

    PubMed  Google Scholar 

  • Reynolds NJ, Franklin V, Gray JC, Diffey BL, Farr PM. Narrow-band ultraviolet B and broad-band ultraviolet. A phototherapy in adult atopic eczema: a randomised controlled trial. Lancet. 2001;357(9273):2012–6.

    Article  CAS  PubMed  Google Scholar 

  • Richter R, Ahrens S. Psychosomatische Aspekte der Allergie in Manuale allergologicum (Fuchs E, Schulz KH) Dustri-Verlag. München Deisenhofen. 1990;8:1–16.

    Google Scholar 

  • Riedler J, Braun-Fahrländer C, Eder W, Schreuer M, Waser M, Maisch S, Carr D, Schierl R, Nowak D, von Mutius E. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358:1129–33.

    Article  CAS  PubMed  Google Scholar 

  • Rigopolous D, Gregoriou S, Charissi C, Kontochristopoulos G, Kalogeromitros D, Georgala S. Tacro-limus ointment 0,1 % in pityriasis alba: an open-label, randomized, placebo-controlled study. Br J Dermatol. 2006;155(1):152–5.

    Article  CAS  Google Scholar 

  • Ring J. Successful hyposensitization treatment in atopic eczema: results of a trial monozygotic twins. Br J Dermatol. 1982b;107:597–602.

    Article  CAS  PubMed  Google Scholar 

  • Ring J. Allergy in practice. Berlin/Heidelberg/New York : Springer; 2005.

    Google Scholar 

  • Ring J. Allergy in practice. Berlin/Heidelberg/New York : Springer; 2005.

    Google Scholar 

  • Ring J, Barker J, Behrendt H, et al. Review of the potential photococareinogenicity of topical calcineurin inhibitors. Position statement of the European Dermatology Forum (JEADV); 2005.

    Google Scholar 

  • Ring J, Möhrenschlager M, Henkel V. The US FDA “black box” warning for topical calcineurin inhibitors. Drug Saf. 2008;31:185–98.

    Article  CAS  PubMed  Google Scholar 

  • Ring J, Abraham A, de Cuyper C, Kim K, Langeland T, Parra V, Pigatto P, Reunala T, Szcepanski R, Möhrenschlager M, Bräutigam M, Rossi AB, Meents-Kopecky E, Schneider D. Control of atopic eczema with pimecrolimus cream 1 % under daily practice conditions: results of a >2000 patient study. J Eur Acad Dermatol Venereol. 2009;22:195–203.

    Article  Google Scholar 

  • Ring J, Abraham A, de Cuyper C, Kim K, Langeland T, Parra V, Pigatto P, Reunala T, Szcepanski R, Möhrenschlager M, Bräutigam M, Rossi AB, Meents-Kopecky E, Schneider D. Control of atopic eczema with pimecrolimus cream 1 % under daily practice conditions: results of a >2000 patient study. J Eur Acad Dermatol Venereol. 2009;22:195–203.

    Google Scholar 

  • Rombold S, Lobisch K, Katzer K, Grazziotin TC, Ring J, Eberlein B. Efficacy of UVA1 phototherapy in 230 patients with various skin diseases. Photodermatol Photoimmunol Photomed. 2008;24:19–23.

    Article  CAS  PubMed  Google Scholar 

  • Rothenberg ME, Klion AD, Roufosse FE, Kahn JE, Weller PF, Simon HU, Schwartz LB, Rosenwasser L, Ring J, Griffin EF, Haig AE, Frewer PIH, Parkin JM, Gleich G. Treatment of patients with the hyper-eosinophilic syndrome with mepolizumab. N Engl J Med. 2008;358:1215–28.

    Article  CAS  PubMed  Google Scholar 

  • Ruzicka T. Atopic eczema between rationality and irrationality. Arch Dermatol. 1998;134:1462–9.

    CAS  PubMed  Google Scholar 

  • Ruzicka T, Bieber T, Schopf E, Rubins A, Dobozy A, Bos JD, Jablonska S, Ahmed I, Thestrup-Pedersen K, Daniel F, Finzi A, Reitamo S. A short-term trial of tacrolimus ointment for the treatment of atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. N Engl J Med. 1997;337(12):816–21.

    Article  CAS  PubMed  Google Scholar 

  • Schäfer T, Riehle A, Wichmann HE, Ring J. Alternative medicine in allergies – prevalence, patterns of use, and costs. Allergy. 2002;57:694–700.

    Article  PubMed  Google Scholar 

  • Schäfer T, Riehle A, Wichmann HE, Ring J. Alternative medicine in allergies – prevalence, patterns of use, and costs. Allergy. 2002;57:694–700.

    Google Scholar 

  • Scheynius A, Johansson C, Buentke E, Zargari A, Linder MT. Atopic eczema/dermatitis syndrome and Malassezia. Int Arch Allergy Immunol. 2002;127:161–9.

    Article  CAS  PubMed  Google Scholar 

  • Schmidt T, Abeck D, Boeck K, Mempel M, Ring J. UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema. Acta Derm Venereol. 1998;78:318–9.

    Article  CAS  PubMed  Google Scholar 

  • Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema – a systematic review and meta-analysis. J Eur Acad Dermatol Venereol. 2007b;21:606–19.

    CAS  PubMed  Google Scholar 

  • Schmitt J, Csotonyi F, Bauer A, Meurer M. Determinants of treatment goals and satisfaction of patients with atopic eczema. J Dtsch Dermatol Ges. 2008;6:458–65.

    Article  PubMed  Google Scholar 

  • Schmitt J, Apfelbacher C, Chen CM, Romanos M, Sausenthaler S, Koletzko S, Bauer CP, Hoffmann U, Krämer U, Berdel D, von Berg A, Wichmann HE, Heinrich J. Infant eczema, infant sleeping problems, and mental health at 10 years of age: the prospective birth cohort study (German Infant Nutrition Intervention plus). J Allergy Clin Immunol. 2010;125:404–10.

    Article  PubMed  Google Scholar 

  • Schmoeckel C, von Liebe V. [Acneiform exanthema caused by azathioprine] (Article in German). Hautarzt. 1983;34:413–5.

    CAS  PubMed  Google Scholar 

  • Schnopp C, Ring J. Therapiestrategien bei atopischem Ekzem. J Med. 2003;3/4:16–20.

    Google Scholar 

  • Schnopp C, Holtmann C, Stock S, et al. Topical steroids under wet-wrap dressings in atopic dermatitis – a vehicle-controlled trial. Dermatology. 2002;204:56–9.

    Article  CAS  PubMed  Google Scholar 

  • Schöni MH, Nikolaizik WH, Schöni-Afolter F. Efficacy trial of bioresonance in children with atopic dermatitis. Int Arch Allergy Immunol. 1997;112:238–46.

    Article  PubMed  Google Scholar 

  • Schram ME, Roekevisch E, Leeflang MMG, Bos JD, Schmitt J, Spuls PI. A randomized trial of methotrexate versus azathioprine for severe atopic eczema. J Allergy Clin Immunol. 2011;128:353–9.

    Article  CAS  PubMed  Google Scholar 

  • Schut C, Weik U, Tews N, Gieler U, Deinzer R, Kupfer J. Psychophysiological effects of stress management in patients with atopic dermatitis: a randomized controlled trial. Acta Derm Venereol. 2013;93:57–61.

    PubMed  Google Scholar 

  • Sheehan MP, Atherton DJ. A controlled trial of traditional Chinese medicinal plants in wide-spread non-exudative atopic eczema. Br J Dermatol. 1992;126:179–84.

    Article  CAS  PubMed  Google Scholar 

  • Shenefelt PD. Hypnosis in dermatology. Arch Dermatol. 2000;136:393–9.

    CAS  PubMed  Google Scholar 

  • Sidbury R, Hanifin JM. Systemic therapy of atopic dermatitis. Clin Exp Dermatol. 2000;25:559–66.

    Article  CAS  PubMed  Google Scholar 

  • Siebenwirth J, Lüdtke R, Remy W, Rakoski J, Borelli S, Ring J. Wirksamkeit von klassisch-homöopathischer Therapie bei atopischem Ekzem. Forsch Komplement Med. 2009;16:315–23.

    Article  Google Scholar 

  • Silny W, Czarnecka-Operacz M. Spezifische Immuntherapie bei der Behandlung von Patienten mit atopischer Dermatitis. Ergebnisse einer placebokontrollierten Doppelblindstudie. Allergologie. 2006;29:171–83.

    Article  Google Scholar 

  • Simon D, Hösli S, Kostylina G, Yawalkar N, Simon HU. Anti-CD20 (rituximab) treatment improves atopic eczema. J Allergy Clin Immunol. 2008;121:122–8.

    Article  CAS  PubMed  Google Scholar 

  • Simons E. Drug therapy. Advances in H1-antihistamines. N Engl J Med. 2004;351:2203–17.

    Article  CAS  PubMed  Google Scholar 

  • Simons FER, Johnston L, Simons KJ. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children. Pediatr Allergy Immunol. 2000;11:116–9.

    Article  CAS  PubMed  Google Scholar 

  • Sokel B, Kent CA, Lansdown R, Atherton D, Glover M, Knibbs J. A comparison of hypnotherapy and biofeedback in the treatment of childhood atopic eczema. Contemp Hypnosis. 1993;10:70–5.

    Google Scholar 

  • Stalder JF, Fleury M, Sourisse M, et al. Comparative effects of two topical antiseptics (chlorhexidine vs KMn04) on bacterial skin flora in atopic dermatitis. Acta Derm Venereol Suppl. 1992;176:132–4.

    CAS  Google Scholar 

  • Ständer S, Schäfer I, Phan NQ, Blome C, Herberger K, Heigel H, Augustin M. Prevalence of chronic pruritus in Germany: results of a cross-sectional study in a sample working population of 11,730. Dermatology. 2010;221:229–35.

    Article  PubMed  Google Scholar 

  • Stangier U, Gieler U, Ehlers A. Autogenes Training bei Neurodermitis. Z Allgemeinmed. 1992;68:392–400.

    Google Scholar 

  • Stangier U, Gieler U, Ehlers A. Neurodermitis bewältigen. Verhaltenstherapie, dermatologische Schulung, autogenes Training. Berlin: Springer; 1996.

    Google Scholar 

  • Stiftung Warentest (Hrsg.). Handbuch Die andere Medizin. Nutzen und Risiken sanfter Heilmethoden. Berlin: Stiftung Warentest; 1994.

    Google Scholar 

  • Suárez AL, Feramisco JD, Koo J, Steinhoff M. Psychoneuroimmunology of psychological stress and atopic dermatitis: pathophysiologic and therapeutic updates. Acta Derm Venereol. 2012;92:7–15.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Sulzberger MB, Witten VH. The effect of topically applied compound F in selected dermatoses. J Invest Dermatol. 1952;19:101–2.

    Article  CAS  PubMed  Google Scholar 

  • Tey HL, Yosipovitch G. Itch in ethnic populations. Acta Derm Venereol. 2010;90:227–34.

    Article  PubMed  Google Scholar 

  • Tudhope SJ, Catley MC, Fenwick PS, et al. The role of I[kappa]B Kinase 2, but not activation of NF[kappa]B, in the release of CXCR3 ligands from IFN-[gamma]-stimulated human bronchial epithelial cells. J Immunol. 2007;179:6237–45.

    Article  CAS  PubMed  Google Scholar 

  • Turpenen M. Absorption of hydrocortisone from the skin reservoir in atopic dermatitis. Br J Dermatol. 1991;124:358–60.

    Article  Google Scholar 

  • Undre NA, Moloney FJ, Ahmadi S, Stevenson P, Murphy GM. Skin and systematic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis. Br J Dermatol. 2009;160:665–9.

    Article  CAS  PubMed  Google Scholar 

  • Vocks E, Borelli S, Busch R, Düngemann H, Ring J. Biometrische Studie zur Wetterabhängigkeit und Wetterempfindlichkeit beim atopischen Ekzem. Act Dermatol. 2002;28:363–9.

    Google Scholar 

  • Von Kobyletzki G, Freitag M, Herde M, Hoxtermann S, Stucker M, Hoffmann K, Altmeyer P. Photo-therapy of atopic dermatitis: comparison between conventional UVA1 phototherapy, UVA1 cold light phototherapy and combined UVA-UVB phototherapy. Hautarzt. 1999;50(1):27–33.

    Article  Google Scholar 

  • Wahlgren CF, Hagermark O, Bergstrom R. The antipruritic effect of a sedative and a non-sedative antihistamine in atopic dermatitis. Br J Dermatol. 1990;122(4):545–51.

    Article  CAS  PubMed  Google Scholar 

  • Wahn U, Bos JD, Goodfield M, Caputo R, Papp K, Manjra A, Dobozy A, Paul C, Molloy S, Hultsch T, Graeber M, Cherill R, de Prost Y, for the Flare Reduction in Ekzema with Elidel (Children) Multicenter Investigator Study Group. Efficacy and safety of pimecrolimus cream in the long-term management of atopic dermatitis in children. Pediatrics. 2002;110:1–8.

    Article  Google Scholar 

  • Wandtke F, Stanek KW, Götz M, Jarisch R. Bioresonanz – Allergietest versus Pricktest und RAST. Allergologie. 1993;16:144–5.

    Google Scholar 

  • Warnecke J, Wendt A. Anti-inflammatory action of pale sulfonated shale oil (ICHTHYOL pale) in UVB erythema test. Inflamm Res. 1998;47:75–8.

    Article  CAS  PubMed  Google Scholar 

  • Weinberg E, Fourie B, Allmann B, Toerien A. The use of cefadroxil in superinfected atopic dermatitis. Curr Ther Res Clin Exp. 1992;52(5):671–6.

    Article  Google Scholar 

  • Werfel T, Breuer K, Rueff F, et al. Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multicentre, randomized, dose-response study. Allergy. 2006;61:202–5.

    Article  CAS  PubMed  Google Scholar 

  • Werfel T, Erdmann S, Fuchs T, et al. Vorgehen bei vermuteter Nahrungsmittelallergie bei atopischer Dermatitis. Allergo J. 2008b;17:476–83, (AWMF Leitlinienregister Nr. 061/010, www.awmf-online.de).

    Google Scholar 

  • Werfel T, Aberer W, Augustin M, et al. Neurodermitis S2-Leitlinie. J Dtsch Dermatol Ges. 2009;7:s1–46.

    PubMed  Google Scholar 

  • Weymayr C, Heissmann, N. Die Homöopathie-Lüge – so gefährlich ist die Lehre von den weißen Kügelchen. Munich: Piper; 2012.

    Google Scholar 

  • Wiesenauer M, Gaus W, Häussler S. Behandlung der Pollinosis mit Galphimia glauca. Allergologie. 1990;13:359–63.

    Google Scholar 

  • Wilkinson JD. Fusidic acid in dermatology. Br J Dermatol. 1998;139 Suppl 53:37–40.

    Article  CAS  PubMed  Google Scholar 

  • Wollenberg A, Sharma S, von Bubnoff D, Geiger E, Haberstok J, Bieber T. Topical tacrolimus (FK506) leads to profound phenotypic and functional alterations of epidermal antigen-presenting dentritic cells in atopic dermatitis. J Allergy Clin Immunol. 2001;107:219–525.

    Article  Google Scholar 

  • Wollenberg A, Reitamo S, Atzori F, Lahfa M, Ruzicka T, Healy E, Giannetti A, Bieber T, Vyas J, Deleuran M. Proactive treatment of atopic dermatitis in adults with 0.1 % tacrolimus ointment. Allergy. 2008;63:742–50.

    Article  CAS  Google Scholar 

  • Wüthrich B, Frei PC, Bircher A, et al. Bioresonanz – diagnostischer und therapeutischer Unsinn. Allergologie. 2006;29:244–9.

    Article  Google Scholar 

  • Yamamoto M, Haruna T, Ueda C, Asano Y, Takahashi H, Iduhara M, Takaki S, Yasui K, Matsuo Y, Arimura A. contribution of itch-associated scratch behavior to the development of skin lesions in Dermatophagoides farina-induced dermatitis model in NC/Nga mice. Arch Dermatol Res. 2009;301:739–46.

    Article  PubMed  Google Scholar 

  • Yanase DJ, David-Bajar K. The leukotriene antagonist montelukast as a therapeutic agent for atopic dermatitis. J Am Acad Dermatol. 2001;44(1):89–93.

    Article  CAS  PubMed  Google Scholar 

  • Yang Q. Acupuncture treatment of 139 cases of neurodermatitis. J Tradit Chin Med. 1997;17:57–8.

    CAS  PubMed  Google Scholar 

  • Yosipovitch G, Bernard JD. Chronic pruritus. N Engl J Med. 2013;368:126–63.

    Article  CAS  Google Scholar 

  • Young SH, Rubin JM, Daman HR, editors. Psychobiological aspects of allergic disorders. New York: Praeger; 1986.

    Google Scholar 

  • Yun JW, Seo JA, Young WH, Koh HJ, Bae IH, Part YH, Lim KM. Antipruritic effects of TRPV1 antagonist in murine atopic dermatitis and itching models. J Invest Dermatol. 2011;131:1576–9.

    Article  CAS  PubMed  Google Scholar 

  • Zachariae H, Cramers M, Herlin T, Jensen J, et al. Non-specific immunotherapy and specific hyposensitization in severe atopic dermatitis. Acta Derm Venereol Suppl. 1985;114:48–54.

    CAS  Google Scholar 

  • Zurbriggen B, Wüthrich B, Cachelin AB, Wili PB, Kägi MK. Comparison of two formulations of cyclosporin A in the treatment of severe atopic dermatitis. A double-blind, single-centre, cross-over pilot study. Dermatology. 1999;198:56–60.

    Article  CAS  PubMed  Google Scholar 

  • Benveniste J, Ducot B, Spira A. Memory of water revisited. Nature. 1994;370:322.

    Article  CAS  PubMed  Google Scholar 

  • Benveniste J, Ducot B, Spira A. Memory of water revisited. Nature. 1994;370:322.

    Article  CAS  PubMed  Google Scholar 

  • Benveniste J, Ducot B, Spira A. Memory of water revisited. Nature. 1994;370:322.

    Google Scholar 

  • Benveniste J, Ducot B, Spira A. Memory of water revisited. Nature. 1994;370:322.

    Google Scholar 

  • Zink A, Gensbaur A, Zirbs M, Seifert F, Leon Suarez I, Mourantchanian V, Weidinger St, Mempel M, Ring J, Ollert M. Targeting IgE in severe atopic dermatitis with a combination of immunoadsorption and omalizumab. Acta Derm Venereol. 2015;in press.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology and Allergology Biederstein, Technische Universitaet Muenchen (TUM), Munich, Bavaria, Germany

    Johannes Ring

  2. Christine Kuehne Center for Allergy Research and Education (CK-CARE), Hochgebirgsklinik (High Altitude Hospital), Davos, Switzerland

    Johannes Ring

Authors
  1. Johannes Ring
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Ring, J. (2016). Special Therapeutic Options and Substances in the Treatment of Atopic Eczema. In: Atopic Dermatitis. Springer, Cham. https://doi.org/10.1007/978-3-319-22243-1_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-22243-1_5

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-22242-4

  • Online ISBN: 978-3-319-22243-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation